Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Bellinvia

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Brain : a Journal of Neurology|March 24, 2022
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort studyEmilio Portaccio, Angelo Bellinvia, Mattia Fonderico, et al.
Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Brain : a Journal of Neurology|March 24, 2022
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort studyEmilio Portaccio, Angelo Bellinvia, Mattia Fonderico, et al.
Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Pageof 3